GPR17 and ischemic stroke: Globally, these data indicate that, in rodents, GPR17 decorates a subset of OPCs committed to differentiation specifically involved in the reaction to myelin damage, setting the stage for the potential exploitation of this membrane receptor as a therapeutic target to promote remyelination after ischaemic stroke [18, 19].